Introduction
composed of two divergent actions, that is, vasodilation by the stimulated release of NO and other vasodilating The endothelium provides a variety of important funcsubstances such as EDHF from the endothelium, and direct tions involved in the cardiovascular homeostasis. The vasoconstricting effects on the underlying vascular smooth assessment of endothelial function in humans has focused muscle, particularly with higher doses. In contrast to primarily on endothelial dependent vasomotion in response acetylcholine, bradykinin-and possibly substance P-is to the release of NO. In particular, clinical studies have likely to play a physiological role. Tissue bradykinin is evaluated vasomotor tone following changes in flow or inactivated by the endothelial angiotensin-converting enstimuli for the release of NO from the endothelium, such zyme [6] and can be released by increased flow [7] . as acetylcholine, substance P or serotonin [1] . However, Endogenous bradykinin appears to be involved in the NO not only acts as a vasodilating substance but also regulation of basal and flow-mediated coronary vasomotor affects other functions of the endothelium such as the tone in humans [8] . However the vasodilator effect of adhesive properties of the endothelium with respect to the bradykinin involves not only NO but also PGI and EDHF. 2 interaction with leucocytes and platelets [2] . Despite the Consistent with these observations clinical studies have pivotal contribution of in vitro studies for the elucidation shown that short and long-term ACE-inhibition enhances of underlying mechanisms, the clinical implication of endothelium-dependent relaxation both in the peripheral endothelial function can only be appreciated by studies in and coronary circulation [9] [10] [11] . There is evidence that NO humans in vivo, since tissue or cells are exposed to an is constantly released from the endothelium in humans artificial environment i.e. lacking the neurohumoral in- [12] . In fact Quyyumi et al. have shown that NO contrifluences present in vivo. To critically review the role of butes to resting epicardial and coronary microvascular NO in coronary endothelial dysfunction in humans the tone. Despite the absence of angiografic evidence of present review focuses on observations made by the in arteriosclerosis, the presence of coronary risk factors is vivo assessment of endothelial dependent vascular reassociated with reduced resting and stimulated bioavailsponses.
ability of NO from the human coronary circulation [13] . The basal release of NO keeps the vasculature in a 'dilated state' and counteracting the vasoconstrictor forces such as 2. Normal endothelial function noradrenalin, angiotensin or endothelin.
In normal individuals increases in blood flow is associated with flow-dependent, endothelium-mediated vasodilat-3. Endothelial function in hypercholesterolemia and ion [3] which is related to the release of NO from the arteriosclerosis endothelium [4, 5] . Similarly, acetylcholine, bradykinin or substance P elicit endothelium-dependent dilation of large
The endothelial vasodilator function is impaired in the and small vessels, which, in part, is due to the stimulated early stages of atherosclerosis. For example, impaired release of NO. However, the effect of acetylcholine, the endothelial dependent vasodilation has been noted in large most commonly used agent in the clinical setting, is conduit and small resistance vessels in patients with hypercholesterolemia without evidence of arteriosclerotic lesions, as assessed by angiography or intravascular ultra-sound [14, 15] . These observations are consistent with and its releasing substances (thromboxane and serotonin) is experimental data suggesting that endothelial dysfunction altered. With normal endothelial function, the release of precedes overt atherosclerosis in experimental models of NO may be associated with vasodilation (counterbalancing hypercholesterolemia and may represent an important early the direct vasoconstricting effects of serotonin and thromevent predisposing conduit vessels to vasospasm and boxan), however, in the face of a defective endothelial vasoconstriction. mediated vasodilation, inappropriate coronary vasoconAssessment of endothelial vasodilator function at differstriction may emerge promoting platelet activation and ent stages of coronary artery disease indicated that a aggregation. progressive deterioration of endothelial function emerges,
In general, the degree of endothelial dysfunction of including early impairment of acetylcholine-induced vasocoronary microvasculature correlates with total serum dilator responses followed by reduced flow-dependent cholesterol levels [22] . However, if the analysis is confined vasodilation [16] . Studies in patients with hypercholesto patients with hypercholesterolemia (rather than to terolemia type IIa, moderately elevated serum cholesterol patients with a wide range of serum cholesterol levels) the levels and angiographically smooth coronary arteries reratio of LDL / HDL appears to correlate more closely than vealed a significant endothelial dysfunction of large cortotal serum cholesterol levels with endothelium-dependent onary arteries and coronary microcirculation [14] . In dilation in the coronary circulation [23] . Based on the patients with hypercholesterolemia, even angiographically presumed functions of HDL and their relationship to the smooth coronary arteries show a striking vasoconstriction efficiency of reverse cholesterol transport in subjects with in response to intracoronary infusion of acetylcholine.
normal and increased LDL levels (for review see [24] [27] . suggested that basal release of NO is impaired in coronary artery disease [18] . Impaired endothelial vasodilator function is reversible, i.e. by short-term administration of by L-arginine, the precursor of NO [19, 20] or following 5. Potential mechanisms for the development of removal of LDL-cholesterol (see below).
endothelial dysfunction
The underlying mechanisms by which risk factors such as hypercholesterolemia or hypertension impair endo-4. Endothelial function in the coronary thelium-dependent relaxation remain to be elucidated. micrcocirculation Several possible mechanisms were proposed including: (a) reduced synthesis of NO (b) altered membrane receptor Impaired endothelium-dependent relaxation is not concoupling mechanisms affecting the release of NO and (c) fined to epicardial coronary arteries but emerges in the impaired diffusion or augmented destruction of NO in the coronary microcirculation particularly in hypercholesvessel wall. Native LDL lipoprotein has been shown to terolemic subjects [14,16] while endothelium-independent increase endothelial cell NO synthase generation of vasodilators exert maximal increases in coronary blood superoxide anion [28] . The inhibitory effect of oxidized flow in hypercholesterolemia. There is experimental evi-LDL (presumed to be accumulated in the vascular wall of dence that under these circumstances, flow-dependent patients with hypercholesterolemia) may be derived from dilation of the coronary microvasculature is abolished [21] .
its ability to interfere with the receptor-operated release of Since this mechanism of dilation of resistance vessels may L-arginine from intracellular stores or the synthesis of the be involved in the increased flow, i.e. during states of amino acid [29] . Alternatively, high-affinity arginine transincreased flow such as reactive hyperemia, the impaired port into endothelial cells may be impaired by lysophosendothelial function of the coronary microvasculature in phatidylcholine, a component of of oxidized LDL [30, 31] ; humans may have important implications for subjects with in fact a caveolar complex exists between the cationic acid hypercholesterolemia. Moreover, the endothelial modulatransporter 1, endothelial NO synthase and caveolin [32] . tion of factors such as sympathetic stimulation or platelets In addition, hypercholesterolemia in patients is associated with increased plasma and tissue levels of asymmetrical striction in response to exercise, cold pressure test or dimethyl-L-arginine (ADMA), inhibiting the NO synthase mental stress [38] [39] [40] despite similar effects on central to generate NO [33] . Thus, in hypercholesterolemia, the hemodynamics or plasma levels of catecholamines. In such intracellular availability of L-arginine may become a ratepatients there is a close relationship between endothelial limiting factor for the production of NO. Conceivably, function and response of the identical coronary segment to hypercholesterolemia may alter the intracellular pathway the cold pressure test. Coronary vasoconstriction is usually for L-arginine or affect the stimulated release of NO.
observed only in segments with acetylcholine-induced Hypercholesterolemia may also affect the NO synthase to epicardial coronary vasoconstriction (indicating endothelial produce superoxide radicals which in turn would be able to dysfunction). Moreover, sympathetic activation is an iminactivate NO [28] . The improvement of endotheliumportant trigger mechanism of myocardial ischemia in dependent dilation within the human coronary circulation patients with coronary artery disease and stable angina. following the administration of L-arginine would be conThere is evidence that exercise induces dynamic vasoconsistent with the hypothesis that by providing the substrate striction at the site of arteriosclerotic lesions [40] . for synthesis of NO, an enhanced formation of NO Conceivably, inappropriate vasoconstriction due to emerges restoring endothelium-dependent dilation. Noendothelial vasodilator dysfunction of atherosclerotic epitably, L-arginine augmented endothelium-dependent dilacardial arteries may play an important role in triggering tion in the coronary microcirculation of patients with myocardial ischemia in patients with (intermediate) corhypercholesterolemia but not in control subjects.
onary stenoses. Even though the extent of coronary vasoconstriction elicited by sympathetic activation is usually less than 25 to 30%, such an increase in arterial tone may be sufficient to convert a non-flow-limiting into a 6. Functional consequences of impaired NO critical stenosis with ensuing decreases in blood flow; i.e. availability in coronary arteries in intermediate coronary lesions of 50-70%. Thus, in coronary lesions with stenoses between 50 and 70% The loss of flow-dependent dilation in atherosclerotic (luminal diameter) an abnormal vasoconstrictor response segments may favor vasoconstriction at sites where vasodidue to the loss of endothelium-mediated vasodilation may lation could ordinarily occur upon an increase in flow.
account for the mismatch between myocardial oxygen Such an impaired response to increased flow may in part supply and demand, with other words, a link may exist explain the abnormal vasomotor responses to physiological between endothelial vasodilator dysfunction at the site of stimuli in daily life such as exercise, mental stress or the stenosis and myocardial ischemia and explain episodes exposure to cold environment. Under normal conditions, of angina associated with daily life activities. flow-mediated dilation represents the major mechanism by Notably, coronary vasomotor tone may be further enwhich the epicardial vessels respond to stimuli, e.g.
hanced by humoral factors released from activated platelets exercise, that increase myocardial work and oxygen deduring ischemia, plaque rupture or simply during circadian mand. NO mediated, shear-induced dilatation opposes the peaks of platelet aggregability. A recent study has shown myogenic vasoconstriction elicited by increases in pressure that intracoronary infusion of serotonin resulting in con- [34, 35] . Endothelial modulation of factors such as sympacentration equivalent to those during platelet activation thetic stimulation or platelets and its releasing substances caused severe epicardial coronary vasoconstriction in (thromboxane and serotonin) is altered. In the face of patients with coronary artery disease and endothelial endothelial dysfunction, the vessel is more sensitive to the dysfunction whereas coronary diameters increased in norconstrictor effects of norepinephrine. Indeed, Vita et al.
mal subjects [41, 42] . Thus, the vasomotor response to have shown that patients with evidence of coronary serotonin is dependent on the integrity of the endothelium. endothelial dysfunction as assessed by acetylcholine, inPlatelet-mediated vasoconstriction may only occur if the tracoronary infusion of phenylephrine was associated with endothelium is dysfunctional. Importantly, the intact endoincreased coronary vasoconstriction as compared to normal thelium plays an important role in maintaining the balance individuals [36] . Similarly, exercise or exposure to cold between proaggregatory and antiaggregatory behaviour of activates the sympathetic nervous system and increases platelets since both NO and prostaglandins inhibit platelet circulating levels of catecholamines. Sympathetic activaaggregation and adhesion. Hence, defective endothelial tion is also accompanied by complex reflex mechanisms function prediposes to the deposition of platelets. Indeed, including increases in heart rate and blood pressure thereby increased platelets adhesion has been demonstrated in enhancing myocardial oxygen demand. In patients with human arteriosclerotic arteries. Vice versa, stimulation of normal coronary arteries exercise and exposure to cold NO release from the vascular endothelium promotes produce dilation of epicardial coronary arteries [37] . In inhibition of platelet aggregation in the human circulation contrast, patients with arteriosclerotic coronary arteries and this inhibitory effect is attenuated in patients with demonstrate 'paradoxical' epicardial coronary vasoconatherosclerosis [43] . Taken together, with normal endothelial function, the 8. Effect of cholesterol lowering by statins on release of NO may be associated with vasodilation (counendothelial dysfunction terbalancing the direct vasoconstricting effects of serotonin and thromboxan), however, in the face of a defective Several longterm studies have applied lipid lowering endothelial mediated vasodilation, inappropriate coronary drugs for several months and evaluated endothelial funcvasoconstriction may emerge promoting platelet activation tion before and after this intervention in patients with and aggregation [44] .
coronary artery disease and hypercholesterolemia. Leung Since experimental data suggest that the endothelium et al. [52] were the first to assess endothelium-dependent plays an important role in maintaining vascular structure and -independent dilation of coronary epicardial arteries [45] , the impaired basal release of atherosclerotic coronary before and 6 months following a lipid-lowering regimen, arteries as demonstrated in vitro may have long-term consisting of dietary restrictions and oral treatment with implications concerning vascular remodelling of coronary cholestyramin. A decrease in plasma cholesterol of approxarteries. Since NO interferes with the action and synthesis imately 30% was achieved at follow-up, in comparison to of endothelin, the lack of NO activity may favor the baseline. Before treatment, intracoronary coronary infusion vascular expression of endothelin. Indeed, increased circuof acetylcholine causes severe vasoconstriction of epicarlating and tissue endothelin immunoreactivity has been dial arteries, whereas a moderate vasodilation was obobserved in patients with coronary artery disease [46] . In served at follow-up. Intracoronary infusion of nitrofact, the expression of endothelin in the coronary circulaglycerine elicited a similar degree of vasodilation at tion is increased in humans with coronary endothelial baseline and follow-up. Egashira et al. studied a small dysfunction [47] .
group of nine hypercholesterolemia patients before and after treatment with pravastatin, an inhibitor of HMG-CoA reductase [53] . The acetylcholine-induced vasoconstriction of the epicardial artery was less and the the acetylcholine-7. Risk factors and endothelial function induced increases in coronary blood flow were greater after pravastatin. In a normocholesterolemic control group the Except for smoking whose impact on epicardial endoeffects of acetylcholine were similar before and after 8 thelial function remains somewhat controversial, all known months. Thus, the lipid lowering intervention (272 to 187 risk factors are associated with endothelial dysfunction of mg / dl) was associated with an improvement of endothelial epicardial coronary arteries. Studies by Vita et al. [48] and function of coronary conduit and resistance vessels. Two Yasue et al. [49] , indicate that the loss of endotheliumcontrolled trials have yielded similar beneficial effects of dependent vasodilation correlates with the presence of HMG-CoA reductase inhibitors on endothelial function in elevated serum cholesterol, male sex, family history of the coronary circulation [54, 55] . In one of the latter trials, coronary artery disease, and age in angiographically northe incidence of angina was reduced [55] . Moreover, mal coronary arteries. Elevated high-density lipoprotein short-term (3 month) cholesterol lowering decreases the levels may have a protective effect on endothelial function size and severity of perfusion abnormalities as assessed by of epicardial coronary arteries [50] . Even a family history positron emission tomography after dipyradamole in hyof premature coronary disease has been shown to be percholesterolemic patients with coronary artery disease associated with impaired endothelial dependent dilation in
[56], myocardial ischemia, angina pectoris [57-59] and young healthy subjects [51] . The more risk factors present, improves coronary flow [60] . The rapid improvement in the more likely the coronary arteries were to constrict. myocardial perfusion is unlikely to be attributed to regresHowever, the presence of a single coronary risk factor, sion of epicvaridal coronary lesions. In fact, seminal such as hypercholesterolemia or hypertension, is sufficient studies by Brown et al. have clearly shown that the extent to impair endothelium-dependent vasomotion in angiogof lesion regression is minimal and if it occurs takes years raphically normal coronary arteries. By multivariate analyto be measureable [61] . Conceivably, improvement of sis, the presence of arteriosclerotic lesions has been endothelial function has contributed to the improved reported to be an independent predictor for impaired blood coronary perfusion following cholesterol lowering with flow responses to acetylcholine. This analysis suggests that statins [60] . The improvement in endothelial function may mild (non-flow-limiting) arteriosclerotic lesions are accomnot only be related to reduction of LDL-cholesterol but to panied by impaired endothelium-dependent dilation of a specific upregulation of the synthesis of NO synthase by coronary resistance vessels. However, a dissociation bestatins which increase the mRNA for the endothelial NO tween the impairment of endothelium-dependent relaxation synthase [62] . In addition, prolonged treatment with statins of conductance and resistance vessels has been reported, may reduce vascular radical formation. Interestingly, lonsuggesting that the presence of different mechanisms gterm therapy with probucol over 1 year combined with underlying the endothelial dysfunction in these two arterial lovastatin was more effective than lovastain given alone in territories may exist.
improving endothelial dysfunction of epicardial coronary arteries [55] . Since probucol acts as an antioxidant with role of oxygen species in the impaired endothelial depenminor effects on lipid plasma levels, these clinical observadent relaxation in coronary artery disease and its risk tions are consistent with experimental data suggesting that factors and are consistent with the notion, that the cellular inactivation of NO may play a prominant role in hyredox state may be an important regulator of endotheliumpercholesterolemia, diabetes and arteriosclerosis.
derived NO. Interestingly, low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome [70] which would support the role of impaired 9. Inactivation of NO as a cause of endothelial endothelial dysfunction in the clinical setting of angina. dysfunction Moreover, the activity of superoxide dismutase in the extracellular space (EC SOD) or in vascular smooth Hypercholesterolemia, diabetes mellitus or heart failure muscle cells (Cu / Zn SOD) may play an important role in are all associated with increased oxidative stress, either due keeping the balance between radical formation and to increased radical formation and / or decreased radical scavenging. scavenging enzyme activity (see Fig. 1 ). Superoxide anions Vitamin E is thought to protect LDL from oxidation production may be enhanced by stimulation of the NADPH within the vascular wall. However, the clinical observaoxidase in response to angiotensin II [63, 64] . Antioxidants tions with vitamin E on the effect on endothelium-depensuch as vitamin C or E, PEG-SOD or probucol have been dent relaxation are conflicting. In our experience the applied clinically to test the concept that inactivation of beneficial effect of longterm vitamin E treatment on NO may play a prominant role in cardiovascular disorders.
endothelium-dependent dilation is confined to patients with In fact, the water soluble antioxidant vitamin C has been increased levels of autoantibodies against oxidized LDL shown to improve endothelium-dependent dilation (and suggesting that vitamin E works only in those patients availability of NO) in patients with hypercholesterolemia, whose endogenous oxygen stress defence mechanisms hypertension, diabetes or coronary artery disease. Imporcannot cope with the generation of oxygen radicals protantly, vitamin C improves endothelium-dependent vasoduced [71] . motor capacity after acute administration [65] and improves myocardial perfusion during long-term therapy [66] , again implying that increased oxidative stress contributes to endothelial dysfunction in hypertensive patients 10. Peripheral endothelial function as a surrogate for with coronary artery disease. Moreover, evidence has been the coronary circulation presented that a weak glutathione related enzymatic antioxidant is present in human atherosclerotic lesions [67] ,
The assessment of endothelial function in the coronary while intracoronary infusion of reduced glutathione imcirculation can only be achieved by cardiac catherization proves endothelial vasomotor response to acetylcholine in and interventional techniques including Doppler flow the human coronary circulation [68] . Furthermore L-2 measurements. In the last 7-8 years several investigators oxothiazolidine-4-carboxylic acid, which augments inhave used a non-invasive approach, introduced by Deantracellular glutathione, improves endothelial-dependent fields group, to identify patients at risk by determining relaxation in patients with coronary artery disease [69] .
endothelial function in peripheral arteries, mostly in the The impressive and instant improvement of NO availabilibrachial artery. Whether or not the evaluation of endothelity following administration of antioxidants supports the al function in the forearm represents a useful surrogate to predict the development of atherosclerosis in humans (i.e. for the clinically more important coronary and cerebral circulation) is an open but a relevant question, given the limitations to evaluate the latter circulatory beds. A comparison of flow-dependent dilation in the brachial artery and acetylcholine-induced coronary vascular response demonstrated a reasonable relationship, although different stimuli for release of NO were used [72] . However, the sensitivity for detecting coronary endothelial dysfunction was only 49% in that study [72] . It is unclear whether or not determination of the same stimuli in the 
